Susquehanna International Group, LLP Kempharm, Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	N/A	177,800 Added 858.94%	198,500 $980,000
Q2 2024 Aug 15, 2024	SELL	N/A	-5,500 Reduced 20.99%	20,700 $102,000
Q1 2024 May 07, 2024	SELL	N/A	-35,200 Reduced 57.33%	26,200 $129,000
Q4 2023 Feb 14, 2024	SELL	N/A	-14,200 Reduced 18.78%	61,400 $303,000
Q3 2023 Nov 14, 2023	SELL	N/A	-41,900 Reduced 35.66%	75,600 $373,000
Q2 2023 Aug 11, 2023	BUY	$4.94 - $6.29 $49,894 - $63,529	10,100 Added 9.4%	117,500 $580,000
Q1 2023 May 16, 2023	SELL	$4.13 - $6.27 $473,298 - $718,542	-114,600 Reduced 51.62%	107,400 $590,000
Q4 2022 Feb 14, 2023	SELL	$4.12 - $5.62 $274,804 - $374,854	-66,700 Reduced 23.1%	222,000 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $51,750 - $78,775	-11,500 Reduced 3.83%	288,700 $1.8 Million

115

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.